Home - Health Sector

COVID-19 UPDATE

As of 27/11/2020

BORNO
Confirmed - 745, Active - 4, Recoveries - 705, Deaths - 36

ADAMAWA
Confirmed - 261, Active - 4, Recoveries - 238, Deaths - 19

YOBE
Confirmed - 94, Active - 12, Recoveries - 73, Deaths - 8

Since the onset of COVID-19

The number of people in need of urgent assistance in North-East Nigeria rose from 7.9 million at the beginning of 2020 to 10.6 million.

Health Sector Bulletin - October 2020

Get more insights on the humanitarian activities of our partners in North East Nigeria.

LEARN MORE

Championing Community Health In North East Nigeria

Communities without functioning health clinics and those living in hard-to-reach areas face serious challenges in accessing health services.

Humanitarian Needs Overview 2020

5.6 Million

People in Need of Healthcare

4.4 Million

People Targeted by the Health Sector

1.9 Million

IDPs in Borno, Adamawa & Yobe

2.1 Million

People Reached in 2020

News & Stories

Health Sector Nutrition updates

Health Sector partners in the North East Nigeria have been providing lifesaving nutrition services in BAY States.

SMC Cycle 3 campaign begins in Borno State

SMC Cycle 3 implementation in Borno State Started on 10th September 2020. Three (3) strategies were used in Cycle 3.

COVID-19 Update for week 39

As of 27th September 2020, a total of 1,051 confirmed cases have been recorded including 60 deaths.

Partners in Focus: September 2020 Activities

ALIMA continue to provide lifesaving medical and nutrition services to disaster affected communities in Northeast Nigeria

Global Health Cluster Key Resources

Photo Story

Country Health Clusters and partners at the global, national and local levels are responding to COVID-19 to protect the world’s most vulnerable groups.

Samaritan's Purse Profile

Samaritan’s Purse is providing essential health and COVID-19 services to indigenous and migrant groups along the Colombian border with Venezuela.

Cash and voucher

The role of Cash and Voucher Assistance to reduce financial barriers in the response to the COVID-19 pandemic, in contexts targeted by the GHRP COVID-19.